Defensol D
- Product NDC
- 53145-005
- 11-digit product format
- 531450005
- Labeler code
- 53145
- Product ID
- 53145-005_3a88bd55-586f-64c5-e063-6394a90a6788
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Chlorpherinamine maleate, Phenylephrine HCI
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Menper Distributors, Inc.
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2012-02-21
- Substance
- ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 325; 2; 5 mg/1; mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 53145-005-30 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 53145-005-02 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 53145-005-30 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 53145-005-02 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 53145-005-30 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 53145-005-02 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 53145-005-30 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 53145-005-02 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 53145-005-30 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 53145-005-02 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 53145-005-30 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 53145-005-02 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 53145-005-02 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 53145-005-30 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Defensol D
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 325 mg/1 |
| CHLORPHENIRAMINE MALEATE | 2 mg/1 |
| PHENYLEPHRINE HYDROCHLORIDE | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| V1Q0O9OJ9Z | Internal UNII lookup |
| 04JA59TNSJ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1046781 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f466c660-69eb-4581-81ff-1499fa421d8b | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d17a97fa-387f-690e-d2be-0083ab044a03 | Product name | 3 | 20170725 |
| 0fdb98e2-b951-a1ce-5715-2b187ba500ef | Product name | 4 | 20170718 |
| c6fba691-a132-4ede-95c6-f8c6bd696636 | Product name | 1 | 20150902 |
| c0200ab5-4954-454e-9676-30b741b245bd | Product name | 1 | 20150730 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53145-005-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3370-f424-e053-dadaa90a57ce | Defensol D |
| 53145-005-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3370-f424-e053-dadaa90a57ce | Defensol D |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53145-005-02 | Defensol D | 50 in 1 CARTON | TABLET | 50 | 5 | |
| 53145-005-02 | Defensol D | 2 in 1 PACKAGE | TABLET | 2 | 5 | |
| 53145-005-30 | Defensol D | 30 in 1 BOTTLE | TABLET | 30 | 5 | |
| 53145-005-30 | Defensol D | 1 in 1 BOX | TABLET | 1 | 5 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| foster and thrive daytime cold and flu relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Strategic Sourcing Services LLC | 067ce5de-dbb4-4b65-8ec0-f4aacbe5e0a6 | 2026-06-16 | Warnings | M012 |
| Equate Severe Cold Cough and Flu | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | WALMART INC. | a35531d7-1a96-45cb-922f-61db085cde1f | 2026-06-16 | Warnings | M012 |
| Cold and Flu Daytime, Nighttime, Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, GUAIFENESIN, PHENYLEPHRINE HCL | Walgreen Company | 5fe9f313-d6e7-41f5-abfc-e4c72b708961 | 2026-06-15 | Warnings | M012 |
| Pain Relief Sinus Congestion | ACETAMINOPHEN, PHENYLEPHRINE HCL | Better Living Brands, LLC | 1d3d6397-0d92-4145-9a70-8bcc45bd0322 | 2026-06-15 | Warnings | M012 |
| Goodmeds Allergy Relief Diphenhydramine HCl | DIPHENHYDRAMINE HYDROCHLORIDE | Cabinet Health P.B.C. | c1cc40f4-9bbb-47f2-ba3b-a5c46ec10f11 | 2026-06-15 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HCL | Rite Aid Corporation | d5d9334d-3db6-4f45-ab84-3e1ec5a752c6 | 2026-06-15 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HCL | Geiss, Destin & Dunn Inc. | fac64ddc-a89b-4d73-b9e5-edc4e5cc3c4b | 2026-06-15 | Warnings | M012 |
| equate daytime cold and flu nighttime cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Wal-Mart Stores Inc | 983a4783-d826-41b6-8087-ca66bcd5b6ca | 2026-06-12 | Warnings | M012 |
| Equate Daytime Nighttime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Wal-Mart Stores Inc | 4173ecde-a2d7-4836-a6e9-fef2270d1b4e | 2026-06-12 | Warnings | M012 |
| PAIN RELIEVER PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Best Choice (Valu Merchandisers Company) | cf370a59-42d5-42fe-882f-09885c55f570 | 2026-06-11 | Warnings | M012 |
| Sudafed Sinus Congestion Plus Cold Severe Day | ACETAMINOPHEN, PSEUDOEPHEDRINE | Kenvue Brands LLC | 537e1a0d-820d-c3f7-e063-6294a90a56ea | 2026-06-10 | Warnings | M012 |
| Sudafed Sinus Congestion plus Cold Severe Day and Night | ACETAMINOPHEN, DIPHENHYDRAMINE, PSEUDOEPHEDRINE | Kenvue Brands LLC | 5382dcad-0337-4440-e063-6394a90a706e | 2026-06-10 | Warnings | M012 |
| good neighbor pharmacy nasal | OXYMETAZOLINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 21cfa71c-7a8f-4100-a42e-9190260653d1 | 2026-06-09 | Warnings | M012 |
| Daytime Nighttime | ACETAMINOPHEN DEXTROMETHORPHAN HBR, ACETAMINOPHEN DEXTROMETHORPHAN HBR TRIPROLIDINE HCL | WALGREENS | 47f1d92f-cb4b-1635-e063-6294a90a2c71 | 2026-06-09 | Warnings | M012 |
| HALLS Honey | MENTHOL | Mondelez Global LLC | 837f5ded-8efb-402b-a1bc-b5c142755660 | 2026-06-09 | Warnings | M012 |
| Daytime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Meijer Distribution Inc | 932b11b1-f4a0-417a-bfa1-05261a172155 | 2026-06-08 | Warnings | M012 |
| NO DRIP NASAL MIST | OXYMETAZOLINE HYDROCHLORIDE | Kroger Company | 957efbcf-b6d3-4793-bb6e-27e99c9be905 | 2026-06-08 | Warnings | M012 |
| DAYTIME SEVERE COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 493caecb-e687-49ea-b7a1-2a5b9376896d | 2026-06-08 | Warnings | M012 |
| Severe Cold and Flu Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | CVS PHARMACY | 4ad10fd7-c088-4356-9d34-a95cfe3a4133 | 2026-06-08 | Warnings | M012 |
| Theraflu Severe Congestion Relief Nasal Mist | OXYMETAZOLINE HCL | Haleon US Holdings LLC | 4ec42064-7390-4137-a93e-57343c3c76a7 | 2026-06-08 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1046781 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet | PSN | f466c660-69eb-4581-81ff-1499fa421d8b | 5 |
| 1046781 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SCD | f466c660-69eb-4581-81ff-1499fa421d8b | 5 |
| 1046781 | APAP 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SY | f466c660-69eb-4581-81ff-1499fa421d8b | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 53145-005-02 | 53145000502 | 50 PACKAGE in 1 CARTON (53145-005-02) / 2 TABLET in 1 PACKAGE | 50 package | 2012-02-21 | No | No | Current |
| 53145-005-30 | 53145000530 | 1 BOTTLE in 1 BOX (53145-005-30) / 30 TABLET in 1 BOTTLE | 1 bottle | 2012-02-21 | No | No | Current |